Home / Resource Library / Economic Evaluation of Brutons Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa

Economic Evaluation of Brutons Tyrosine Kinase Inhibitors for Chronic Lymphocytic Leukaemia in South Africa

Study examined the cost effectiveness of BTK inhibitors for CLL in south africa.